JPRN-UMIN000003090已完成1 期
A phase I trial of stereotactic body radiotherapy for limited hepatocellular carcinoma - HCC-SBRT P1 Study
Division of Radiation Oncology and division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan0 个研究点目标入组 12 人开始时间: 2010年1月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Uncontrolled ascites 2) Gastric/esophageal varix which needs preventive treatment 3) Tumor thrumbus in main trunk of portal vein or IVC 4) Case with critical complication 5) Simultaneous cancer 6) In pregnancy or with expectation of pregnancy
研究者
相似试验
招募中
1 期
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerprostate cancerJPRN-jRCT1030220062Yamashita Hideomi36
进行中（未招募）
1 期
Phase I trial of stereotactic body radiotherapy with concurrent pembrolizumab in metastatic urothelial cancer.Metastatic urothelial cancerEUCTR2016-001263-37-BEZ Gent20
已完成
1 期
A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors.lung tumorJPRN-UMIN000005061Department of Radiology, Nagoya City University Graduate School of Medical Sciences35
已完成
不适用
Phase II trial of stereotactic body radiotherapy for non-spine bone metastases.non-spine bone metastasesJPRN-UMIN000033132Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital35
已完成
2 期
Phase II trial of stereotactic body radiotherapy with a hydrogel spacer for prostate cancerProstate cancerJPRN-UMIN000026213The University of Tokyo Hospital42